SLGL
Sol-GelCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SLGL vs peer average
57/100
SLGL vs. peer average (C vs. C)
Grade spread
A 2 · B 1 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ABOS is the first available peer comparator.
Small-cap clinical biotech comparator for single-program readout risk, capital markets dependence, and event-driven valuation swings.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SLGL
Sol-Gel
ABOS
Acumen
Grade
C
A
Momentum
68
72
Value
44
42
Sentiment
43
76
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ABOS
SLGL / ABOS
Grade Position
In line
SLGL vs. peer average (C vs. C)
57/100
Momentum
68
ABOSValue
44
SLGLSentiment
43
ABOSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SLGL
ABOS is the first peer returned for this comparison set.

